HomeCTMX • NASDAQ
add
CytomX Therapeutics Inc
Previous close
$1.75
Day range
$1.83 - $1.93
Year range
$1.04 - $5.85
Market cap
147.66M USD
Avg Volume
12.33M
P/E ratio
9.58
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 41.46M | 76.45% |
Operating expense | 29.81M | 2.24% |
Net income | 13.79M | 516.52% |
Net profit margin | 33.26 | 336.05% |
Earnings per share | 0.17 | 440.00% |
EBITDA | 12.12M | 339.70% |
Effective tax rate | 0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 150.28M | -26.51% |
Total assets | 184.69M | -21.29% |
Total liabilities | 216.37M | -32.65% |
Total equity | -31.68M | — |
Shares outstanding | 77.92M | — |
Price to book | -3.80 | — |
Return on assets | 15.08% | — |
Return on capital | -111.48% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 13.79M | 516.52% |
Cash from operations | -26.04M | -378.59% |
Cash from investing | 44.88M | 130.61% |
Cash from financing | 174.00K | — |
Net change in cash | 19.01M | 113.85% |
Free cash flow | -10.50M | -131.23% |
About
Founded
2008
Headquarters
Website
Employees
121
